Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 32126 | 112 | 30.5 | 39% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 202 | 20434 | CLOPIDOGREL//PRASUGREL//ASPIRIN RESISTANCE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ENDOTHELAEMIA | Author keyword | 1 | 100% | 2% | 2 |
| 2 | INTERDISCIPLINARY ONCOLEXPT THER EUT PROGR | Address | 1 | 50% | 1% | 1 |
| 3 | ENDOTHELEMIA | Author keyword | 0 | 33% | 1% | 1 |
| 4 | FRIEMANN LIFE SCI | Address | 0 | 33% | 1% | 1 |
| 5 | HYDRAZINOPYRIDAZINE | Author keyword | 0 | 25% | 1% | 1 |
| 6 | N NITROSO | Author keyword | 0 | 25% | 1% | 1 |
| 7 | ENDOTHELIUM DAMAGE | Author keyword | 0 | 20% | 1% | 1 |
| 8 | BETA BLOCKING ACTIVITY | Author keyword | 0 | 17% | 1% | 1 |
| 9 | CARDIOVASC CVRI | Address | 0 | 14% | 1% | 1 |
| 10 | 1 2 4 TRIAZINONE | Author keyword | 0 | 13% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ENDOTHELAEMIA | 1 | 100% | 2% | 2 | Search ENDOTHELAEMIA | Search ENDOTHELAEMIA |
| 2 | ENDOTHELEMIA | 0 | 33% | 1% | 1 | Search ENDOTHELEMIA | Search ENDOTHELEMIA |
| 3 | HYDRAZINOPYRIDAZINE | 0 | 25% | 1% | 1 | Search HYDRAZINOPYRIDAZINE | Search HYDRAZINOPYRIDAZINE |
| 4 | N NITROSO | 0 | 25% | 1% | 1 | Search N+NITROSO | Search N+NITROSO |
| 5 | ENDOTHELIUM DAMAGE | 0 | 20% | 1% | 1 | Search ENDOTHELIUM+DAMAGE | Search ENDOTHELIUM+DAMAGE |
| 6 | BETA BLOCKING ACTIVITY | 0 | 17% | 1% | 1 | Search BETA+BLOCKING+ACTIVITY | Search BETA+BLOCKING+ACTIVITY |
| 7 | 1 2 4 TRIAZINONE | 0 | 13% | 1% | 1 | Search 1+2+4+TRIAZINONE | Search 1+2+4+TRIAZINONE |
| 8 | CV DISEASE | 0 | 13% | 1% | 1 | Search CV+DISEASE | Search CV+DISEASE |
| 9 | PHENOXYPROPANOLAMINE | 0 | 11% | 1% | 1 | Search PHENOXYPROPANOLAMINE | Search PHENOXYPROPANOLAMINE |
| 10 | ELECTRODE CUFF | 0 | 100% | 1% | 1 | Search ELECTRODE+CUFF | Search ELECTRODE+CUFF |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SYMPATHETIC BIAS | 2 | 67% | 2% | 2 |
| 2 | AUTONOMIC BALANCE | 2 | 29% | 4% | 5 |
| 3 | ADRENERGIC HYPERSENSITIVITY | 0 | 33% | 1% | 1 |
| 4 | ACE INHIBITOR TREATMENT | 0 | 20% | 1% | 1 |
| 5 | XENOHORMESIS | 0 | 17% | 1% | 1 |
| 6 | BRANCHED PRIMARY AMINES | 0 | 13% | 1% | 1 |
| 7 | HOUSEHOLD AGGREGATION | 0 | 10% | 1% | 1 |
| 8 | LONG TERM DRIFT | 0 | 10% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| A STANDARDIZED INVIVO MODEL FOR THE STUDY OF EXPERIMENTAL ARTERIAL THROMBOSIS - DESCRIPTION OF A METHOD | 1984 | 8 | 7 | 86% |
| INVIVO ARTERIAL PLATELET-VESSEL WALL INTERACTION AND THROMBOSIS - INDUCTION, ONLINE REGISTRATION AND ULTRASTRUCTURAL CONTROL | 1985 | 0 | 13 | 69% |
| Adventitia contribution to vascular contraction: Hints provided by tissue-engineered substitutes | 2007 | 11 | 90 | 1% |
| Endothelial apoptosis - Could it have a role in the pathogenesis and treatment of disease? | 2000 | 113 | 168 | 1% |
| Paradoxical strategy for treating chronic diseases where the therapeutic effect is derived from compensatory response rather than drug effect | 2005 | 12 | 85 | 1% |
| Can thromboembolism be the result, rather than the inciting cause, of acute vascular events such as stroke, pulmonary embolism, mesenteric ischemia, and venous thrombosis?: a maladaptation of the prehistoric trauma response | 2005 | 14 | 125 | 1% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | INTERDISCIPLINARY ONCOLEXPT THER EUT PROGR | 1 | 50% | 0.9% | 1 |
| 2 | FRIEMANN LIFE SCI | 0 | 33% | 0.9% | 1 |
| 3 | CARDIOVASC CVRI | 0 | 14% | 0.9% | 1 |
| 4 | MILWAUKEE HEART | 0 | 10% | 0.9% | 1 |
| 5 | INTERDISCIPLINARY ONCOLTHORAC ONCOL PROGRAM | 0 | 100% | 0.9% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000146767 | INDOBUFEN//INDOBUFEN ENANTIOMERS//ATHEROSCLEROSIS PERIPHERAL |
| 2 | 0.0000146204 | AGE RELATED DECREASE IN PGI2 PRODUCTION//EN FACE TECHNIQUE//15 ISOPROSTANE F 2T |
| 3 | 0.0000083508 | CARANE DERIVATIVES//AII RECEPTORS//BLOOD PLATELET |
| 4 | 0.0000083448 | POST PROGRAM PSYCHIAT MENTAL HLTH//ATTENT DEFICIT STUDY GRP GEDA//GRP OBES EATING DISORDERS GOTA |
| 5 | 0.0000082615 | PUP IN A CUP//ME5 LESIONS//ARTIFICIAL REARING TECHNIQUE |
| 6 | 0.0000074117 | 4150 CLEMENT ST//MED COLUMBIA//AEROBIC WORK CAPACITY |
| 7 | 0.0000066572 | VESSEL WALL INJURY//INTERDISCIPLINARY EXCELLENCE PROGRAM HLTH AGI//CLIN BIOCHEM IMMUNOHEMATOL |
| 8 | 0.0000066366 | SMALL ANGLE AND WIDE ANGLE X RAY SCATTERING//ARETAIEO UNIV HOSP//MMK3 |
| 9 | 0.0000063979 | ANTITHROMBUS//GUINEACORN//TRICLYCERIDE |
| 10 | 0.0000062050 | POSTJUNCTIONAL ALPHA 2 ADRENOCEPTORS//UK14304//ALPHA 1 ADRENOCEPTORS |